Ocularis Pharma Inc - Company Review
Ocularis Pharma Inc - Company ReviewSummary
Ocularis Pharma Inc (Ocularis), formerly HMT Pharma, Inc is a healthcare products provider that offers drug products. The company provides products to improve vision quality and performance. Its products include nyxol eye drop, which is used for the treatment of non-disease related NVCs such as dissatisfaction to inability to drive at night. Ocularis’ nyxol contains phentolamine mesylate, an alpha-1 antagonist that limits pupil dilation by inhibiting the iris dilator muscles. The company conducts various clinical studies and market research studies to establish its products in the market. It distributes its products in different parts of the world. Ocularis is headquartered in North Riverside, Illinois, the US.
This comprehensive company report of Ocularis Pharma Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.